In vitro and in ovo experimental study of two anti-VEGF agents used in ophthalmology

Anti-vascular endothelial growth factor (anti-VEGF) monoclonal antibodies can inhibit neovascularization and also to block the growth of several tumor cell lines. Treatment with anti-VEGF drugs like Bevacizumab (Avastin(®)) and Aflibercept has proven optimistic results in various malignant diseases....

Descripción completa

Detalles Bibliográficos
Autores principales: Palfi, Mădălina-Casiana, Muşat, Ovidiu, Şeclăman, Edward Paul, Munteanu, Mihnea, Milcu, Adina-Iuliana, Iordache, Andreea, Dolghi, Alina, Istrate, Sînziana Luminiţa, Barac, Ileana Ramona, Borugă, Veronica Mădălina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019627/
https://www.ncbi.nlm.nih.gov/pubmed/35263409
http://dx.doi.org/10.47162/RJME.62.3.18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019627/
https://www.ncbi.nlm.nih.gov/pubmed/35263409
http://dx.doi.org/10.47162/RJME.62.3.18

Ejemplares similares